Evidence map›Paper›PMID 41858476›Full record

SynthesisFrontiers in psychology2026

A COSMIN-based systematic review of the measurement properties of cross-cultural versions of the orthorexia nervosa inventory.

Hanqing Zhang, Chaolumen Bao

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hanqing ZhangThe Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Chaolumen BaoThe Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Orthorexia nervosa (ON) has attracted increasing attention in recent years, and the Orthorexia Nervosa Inventory (ONI) is one of the most widely used instruments for assessing ON. As research on ON expands across different cultural contexts, multiple countries have conducted translation and cultural adaptation studies of the ONI. However, the methodological quality of these translation procedures and the psychometric properties of the adapted versions have not yet been systematically synthesized and compared. Guided by the COSMIN framework, this systematic review aimed to evaluate the measurement quality of cross-culturally adapted ONI versions and to provide evidence for the standardized use of the ONI in clinical and research settings. Methods: This systematic review followed the COSMIN and PRISMA recommendations and was prospectively registered in PROSPERO (CRD420251218905). Using "Orthorexia Nervosa Inventory" and related terms, we systematically searched PubMed, Scopus, the Web of Science, Embase, and the China National Knowledge Infrastructure (CNKI) up to November 2025. We included peer-reviewed original studies published in English or Chinese that reported the translation and/or cultural adaptation of the ONI and its psychometric properties. Furthermore, two reviewers independently performed study selection and data extraction. Translation and adaptation methods were appraised using "Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures" from Beaton et al. Measurement properties were evaluated using the quality criteria of Terwee et al. and the COSMIN Risk of Bias checklist across domains including structural validity, internal consistency, reliability, measurement error, construct validity, and responsiveness. A narrative synthesis was conducted. Results: The search yielded 280 records, of which five studies met the inclusion criteria, covering four countries and five language versions of the ONI (Chinese, Italian, Hungarian, and two Turkish versions). There was substantial heterogeneity in translation and cultural adaptation procedures. Only one Turkish version fully reported all five steps recommended by Beaton's guidelines. Approximately 80% of the studies fulfilled the requirements for forward-backward translation and synthesis, whereas only approximately 40% reported an expert committee review and 40% reported pretesting. According to COSMIN ratings, approximately 60% of the studies were judged "very good" for structural validity, with the majority of versions supported by exploratory factor analysis (EFA) and/or confirmatory factor analysis (CFA) that broadly confirmed the intended factor structure. All five studies reported acceptable internal consistency (Cronbach's α or Conclusion: Existing cross-cultural versions of the ONI demonstrate generally good internal consistency and preliminary support for structural validity. Nonetheless, important gaps remain in the rigor of translation procedures, test-retest reliability, measurement error, and construct validity, with a striking absence of evidence on cross-cultural validity and responsiveness. Future research should rigorously adhere to established cross-cultural adaptation guidelines and COSMIN methodological standards, incorporate multi-group CFA to examine measurement invariance, and comprehensively assess test-retest reliability, measurement error, and responsiveness. In addition, clinically and functionally meaningful cut-off scores should be established to enhance the applicability and comparability of the ONI across diverse cultural contexts. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251218905, Identifier: CRD420251218905.

Indexed as

COSMINeating disorderinstrument validationorthorexia nervosapsychometric properties

Identifiers

PMID41858476
PMCPMC12996259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.